HELX · Franklin Templeton

Franklin Genomic Advancements ETF

See how 63 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.

Holdings dated 30 June 2026Price US$43.79 as of 2 October 2026Meets ratio/fox coverage standard

Core valuation

Trailing P/E827.37×99.18% of 98.73% disclosed weight

Latest-quarter run-rate P/E100.20×99.38% of 98.73% disclosed weight

Trailing P/S6.64×98.07% of 98.73% disclosed weight

Latest-quarter run-rate P/S5.62×98.07% of 98.73% disclosed weight

Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 98.73% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.

Largest reported holdings

Largest reported ETF holdings with weights and trailing valuation ratios
Holding	Weight	Trailing P/E	Trailing P/S
GHGUARDANT HEALTH INC COM	9.09%	-51.72×	19.82×
NTRANATERA INC COM	7.46%	-306.11×	21.75×
KRYSKRYSTAL BIOTECH INC COM	6.33%	39.88×	21.86×
LGNDLIGAND PHARMACEUTICALS INC COM NEW	4.62%	30.60×	20.77×
ADPTADAPTIVE BIOTECHNOLOGIES CORP COM	3.99%	-68.41×	14.18×
UTHRUNITED THERAPEUTICS CORP COM	3.51%	18.69×	7.77×
BBIOBRIDGEBIO PHARMA INC COM	3.50%	-18.91×	18.34×
LLYELI LILLY & COMPANY COM	2.95%	40.52×	13.59×
TWSTTWIST BIOSCIENCE CORP COM	2.85%	-86.25×	27.31×
VRTXVERTEX PHARMACEUTICALS INC COM	2.75%	29.16×	10.20×

Top 10 of 63 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.

Most similar funds

Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.

GNOM · Global X Genomics & Biotechnology ETF29.56% holdings overlap · Nasdaq
IBB · iShares Biotechnology ETF27.33% holdings overlap · US market
FBT · First Trust NYSE Arca Biotechnology Index Fund25.27% holdings overlap · NYSE Arca
BBH · VanEck Biotech ETF25.25% holdings overlap · Nasdaq
ARKG.L · ARK Genomic Revolution UCITS ETF23.99% holdings overlap · London Stock Exchange

Sources and limitations

Holdings are sourced from Franklin Templeton and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.

Open official holdings source

Research holdings date: 30 June 2026. Informational research, not investment advice.